Escherichia coli ‐Induced cGLIS3‐Mediated Stress Granules Activate the NF‐κB Pathway to Promote Intrahepatic Cholangiocarcinoma Progression
Advanced Science · 2024
DOI: 10.1002/advs.202306174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Feng-Ping Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma, Disease Progression, Escherichia coli. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare, Major Scientific Research Project of Young and Middle-aged people of Fujian Provincial Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Patients with concurrent intrahepatic cholangiocarcinoma (ICC) and hepatolithiasis generally have poor prognoses. Hepatolithiasis is once considered the primary cause of ICC, although recent insights indicate that bacteria in the occurrence of hepatolithiasis can promote the progression of ICC. By constructing in vitro and in vivo ICC models and patient‐derived organoids (PDOs), it is shown that Escherichia coli induces the production of a novel RNA, circGLIS3 (cGLIS3), which promotes tumor growth. cGLIS3 binds to hnRNPA1 and G3BP1, resulting in the assembly of stress granules (SGs) and suppression of hnRNPA1 and G3BP1 ubiquitination. Consequently, the IKKα mRNA is blocked in SGs, decreasing the production of IKKα and activating the NF‐κB pathway, which finally results in chemoresistance and produces metastatic phenotypes of ICC. This study shows that a combination of Icaritin (ICA) and gemcitabine plus cisplatin (GP) chemotherapy can be a promising treatment strategy for ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
- Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, 350001, China.
- Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
- Fujian Key Laboratory of Geriatrics, Fujian Provincial Hospital, Fuzhou, 350001, China.
ORCID-Profile: Zhi-Wen Chen, Zu-Wei Wang, Shi Chen
Förderung
- Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare
- Major Scientific Research Project of Young and Middle-aged people of Fujian Provincial Health Commission
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province of China
- Special Funding Project of Fujian Provincial Department of Finance
Zitieren
APA
Kang, F. P., Chen, Z. W., Liao, C. Y., Wu, Y. D., Li, G., Xie, C. K., Lin, H. Y., Huang, L., Tian, Y. F., Wang, Z. W., & Chen, S. (2024). Escherichia coli ‐Induced cGLIS3‐Mediated Stress Granules Activate the NF‐κB Pathway to Promote Intrahepatic Cholangiocarcinoma Progression. Advanced Science. https://doi.org/10.1002/advs.202306174
Vancouver
Kang FP, Chen ZW, Liao CY, Wu YD, Li G, Xie CK, et al. Escherichia coli ‐Induced cGLIS3‐Mediated Stress Granules Activate the NF‐κB Pathway to Promote Intrahepatic Cholangiocarcinoma Progression. Advanced Science. 2024. doi:10.1002/advs.202306174
BibTeX
@article{Kang2024,
author = {Kang, Feng-Ping and Chen, Zhi-Wen and Liao, Cheng-Yu and Wu, Yong-Ding and Li, Ge and Xie, Cheng-Ke and Lin, Hong-Yi and Huang, Long and Tian, Yi-Feng and Wang, Zu-Wei and Chen, Shi},
title = {Escherichia coli ‐Induced cGLIS3‐Mediated Stress Granules Activate the NF‐κB Pathway to Promote Intrahepatic Cholangiocarcinoma Progression},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202306174}
}
EUVIMED